Ming Xiang has completed her PhD from Tongji Medical College, Huazhong University of Science and Technology. She is the Vice Director of School of Pharmacy, Tongji Medical College. She is a qualified Professor with track record not only within the pathogenesis of autoimmune diseases and chronic inflammation, the mechanism of regulation and induction of antigen-specific immune tolerance by Treg and DC for the therapy of autoimmune disease, but also the mechanism of pancreatic oncogenesis. She has published more than 25 papers in reputed journals and has been serving as an Editorial Board Member of repute, obtained 2 patents, an Academic Award and hosted several NSFC projects Ming Xiang has completed her PhD from Tongji Medical College, Huazhong University of Science and Technology. She is the Vice Director of School of Pharmacy, Tongji Medical College. She is a qualified Professor with track record not only within the pathogenesis of autoimmune diseases and chronic inflammation, the mechanism of regulation and induction of antigen-specific immune tolerance by Treg and DC for the therapy of autoimmune disease, but also the mechanism of pancreatic oncogenesis. She has published more than 25 papers in reputed journals and has been serving as an Editorial Board Member of repute, obtained 2 patents, an Academic Award and hosted several NSFC projects

Gastroenterology